Pramlintide
- Generic Name
- Pramlintide
- Brand Names
- Symlin
- Drug Type
- Small Molecule
- Chemical Formula
- C171H267N51O53S2
- CAS Number
- 151126-32-8
- Unique Ingredient Identifier
- D3FM8FA78T
Overview
Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.
Background
Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.
Indication
用于1型和2型糖尿病的辅助治疗。
Associated Conditions
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath